Outcome | Primarya n = 136/170 | Secondarya n = 114/170 | Undetermineda n = 34/170 |
---|---|---|---|
Mortality, n studies (%) | n = 17/136 (13) | 82/114 (72) | 22/34 (65) |
ICU mortality | 2 | 46 | 17 |
Hospital mortality | 4 | 44 | 13 |
Day-28 mortality | 5 | 20 | 4 |
Day-29 to day-89 mortality | 4 | 5 | 1 |
Day-90 mortality | 2 | 7 | 0 |
>Day-90 mortality | 0 | 15 | 6 |
Length of stay, n studies (%) | 4/136 (3) | 90/114 (79) | 21/34 (62) |
ICU length of stay | 4 | 84 | 21 |
Hospital length of stay | 0 | 61 | 9 |
Duration of organ dysfunction, n studies (%) | 12/136 (9) | 75/114 (66) | 14/34 (41) |
Mechanical ventilation | 6 | 56 | 10 |
Catecholamine infusion | 0 | 5 | 1 |
Renal replacement therapy | 0 | 13 | 0 |
Organ failure | 6 | 35 | 6 |
Antibiotic therapy | 0 | 13 | 1 |
Complications, n studies (%) | 65/136 (48) | 74/114 (65) | 30/34 (88) |
Infections | 27 | 48 | 21 |
Metabolic | 19 | 24 | 12 |
Feeding intolerance | 19 | 24 | 9 |
Functional outcome, n studies (%) | 5/136 (4) | 12/114 (11) | 1/34 (3) |
Quality of life | 1 | 7 | 0 |
Physical functionb | 2 | 6 | 1 |
Muscle strength | 1 | 6 | 0 |
Walking distance | 1 | 2 | 0 |
Others, n studies (%) | 33/136 (24) | 16/114 (14) | 12/34 (35) |
Metabolic concentrationc | 12 | 13 | 7 |
Feeding measuresd | 17 | 3 | 4 |
Tube placement (time needed or success) | 3 | 0 | 0 |
Contamination of packs and glass bottles | 1 | 0 | 0 |